Resilience
VC Fund
La Jolla, United States
Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Resilience invests in
Stages Resilience invests in
Countries Resilience invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 17 contacts → | |||
Round size
- Seed
- $1.2M–$6M
Investment Focus
Industry
- Biotechnology 3 (50%)
- B2B 1 (17%)
- IaaS 1 (17%)
- AgTech 1 (17%)
- Analytics 1 (17%)
Stage
- Seed 3 (50%)
- Series A 1 (17%)
- Series B 1 (17%)
Country
- United States 3 (50%)
- Mali 1 (17%)
- United Kingdom 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bill Reid
CISO and VP, Security and Privacy
|
CISO and VP, Security and Privacy | Total investments: 0 | Find email | |
Eytan Abraham
VP, Head of Cell Therapy Franchise
|
VP, Head of Cell Therapy Franchise | Total investments: 0 | Find email | |
Rahul Singhvi
Co-Founder & CEO
|
Co-Founder & CEO | Total investments: 0 | Find email | |
Ross Leimberg
Senior Director of Business Development
|
Senior Director of Business Development | Total investments: 0 | Find email | |
Sandy Mahatme
President, COO and CFO
|
President, COO and CFO | Total investments: 0 | Find email | |
| See all 17 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PartnerSlate is an online platform that helps food and beverage brands make the right strategic partnerships to get their next product to market. Brands can discover, connect, and build relationships with contract manufacturers and other food industry partners across North America. | $4M / Seed / Jun 09, 2023 | ||
| Cellevolve Bio is a development and commercialization company focused on cell therapies. | $6M / Seed / Nov 18, 2021 | ||
| Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation. | $103M / Series B / Nov 05, 2021 | ||
| Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. | $72M / Series A / Sep 23, 2021 | ||
| OKO uses satellite information to define risk and create insurance products for farmers in emerging markets. They use mobile technologies to distribute insurance, collect premiums, help farmers and pay claims. | $1.2M / Seed / Apr 21, 2021 | ||
| See all 6 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Resilience invest in?
Resilience invests primarily in Biotechnology, B2B and IaaS startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Resilience's check size?
Resilience typically joins rounds of $1.2M–$6M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Resilience participates in.
How do I contact Resilience?
Public channels for Resilience include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Resilience?
The team at Resilience includes Bill Reid (CISO and VP, Security and Privacy), Eytan Abraham (VP, Head of Cell Therapy Franchise) and Rahul Singhvi (Co-Founder & CEO), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
